"The Patch" for Depression

Emsam developed by Somerset Pharmaceuticals is the first “patch” to be approved by the FDA for the treatment of depression. One of the biggest hurdles for people is taking their medications on a regular basis. For many people it can be very easy to forget medications if they don’t often take medications or if they take multiple medications. So the development of an antidepressant distributed through a patch might help increase compliance and therefore the efficacy of the treatment program.

Emsam (Selegiline) is a MAOI (monoamine oxidase inhibitor) type of antidepressant that are very effective but do have more side effects than the SSRIs (Prozac, Paxil, etc). C-Health reports Although health officials say MAOIs are safe when used correctly, the drugs can cause dangerous interactions, including sudden and severe rises in blood pressure that can lead to stroke and death, when patients consume food or drinks that contain a substance called tyramine. The substance is found in draft beer, red wine, fava beans, salamis, aged cheeses, soy sauce and other products. Bristol-Myers and Somerset said Emsam patients, when using the six-milligram or lowest strength patch, shouldn't have to watch their diets. That represents a "significant advance" over other MAOIs typically taken in pill form, said Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research.

This exciting treatment option provides more ways for people to receive the treatment that they need for a very treatable illness but medication is only one tool to getting better. Research indicates the best and most effective treatment for depression is a combination of medication and counseling or therapy. Contact us for a FREE consultation.